{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:04:02Z","timestamp":1781327042909,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12944-018-0922-2","type":"journal-article","created":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T17:11:45Z","timestamp":1545844305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Association between E469K polymorphism in the ICAM1 gene and the risk of diabetic nephropathy: a meta-analysis"],"prefix":"10.1186","volume":"17","author":[{"given":"Liya","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongling","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,26]]},"reference":[{"key":"922_CR1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1900\/RDS.2011.8.392","volume":"8","author":"HJ Heerspink","year":"2011","unstructured":"Heerspink HJ, de Zeeuw D. The kidney in type 2 diabetes therapy. Rev Diabet Stud. 2011;8:392\u2013402.","journal-title":"Rev Diabet Stud"},{"key":"922_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3810\/pgm.2012.07.2571","volume":"124","author":"S Cornell","year":"2012","unstructured":"Cornell S, Dorsey VJ. Diabetes pharmacotherapy in 2012: considerations in medication selection. Postgrad Med. 2012;124:84\u201394.","journal-title":"Postgrad Med"},{"key":"922_CR3","volume-title":"Recent advances in diabetic nephropathy: Pergamon press","author":"SM Marshall","year":"2004","unstructured":"Marshall SM. Recent advances in diabetic nephropathy: Pergamon press; 2004."},{"key":"922_CR4","doi-asserted-by":"publisher","first-page":"294","DOI":"10.2174\/157339910793360851","volume":"6","author":"K Kaul","year":"2010","unstructured":"Kaul K, Hodgkinson A, Tarr JM, Kohner EM, Chibber R. Is inflammation a common retinal-renal-nerve pathogenic link in diabetes? Curr Diabetes Rev. 2010;6:294\u2013303.","journal-title":"Curr Diabetes Rev"},{"key":"922_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrneph.2011.51","volume":"7","author":"JF Navarro-Gonzalez","year":"2011","unstructured":"Navarro-Gonzalez JF, Mora-Fernandez C, Muros de Fuentes M, Garcia-Perez J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol. 2011;7:327\u201340.","journal-title":"Nat Rev Nephrol"},{"key":"922_CR6","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1517\/13543784.2011.591785","volume":"20","author":"MC Thomas","year":"2011","unstructured":"Thomas MC, Groop PH. New approaches to the treatment of nephropathy in diabetes. Expert Opin Investig Drugs. 2011;20:1057\u201371.","journal-title":"Expert Opin Investig Drugs"},{"key":"922_CR7","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/genes4040596","volume":"4","author":"E Brennan","year":"2013","unstructured":"Brennan E, McEvoy C, Sadlier D, Godson C, Martin F. The genetics of diabetic nephropathy. Genes (Basel). 2013;4:596\u2013619.","journal-title":"Genes (Basel)"},{"key":"922_CR8","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/157339912799424537","volume":"8","author":"A Gonzalez-Bulnes","year":"2012","unstructured":"Gonzalez-Bulnes A, Ovilo C. Genetic basis, nutritional challenges and adaptive responses in the prenatal origin of obesity and type-2 diabetes. Curr Diabetes Rev. 2012;8:144\u201354.","journal-title":"Curr Diabetes Rev"},{"key":"922_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/MED.0b013e328355b7fe","volume":"19","author":"G Morahan","year":"2012","unstructured":"Morahan G. Insights into type 1 diabetes provided by genetic analyses. Curr Opin Endocrinol Diabetes Obes. 2012;19:263\u201370.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"922_CR10","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1086\/323501","volume":"69","author":"NJ Cox","year":"2001","unstructured":"Cox NJ, Wapelhorst B, Morrison VA, Johnson L, Pinchuk L, Spielman RS, et al. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet. 2001;69:820\u201330.","journal-title":"Am J Hum Genet"},{"key":"922_CR11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/346425a0","volume":"346","author":"TA Springer","year":"1990","unstructured":"Springer TA. Adhesion receptors of the immune system. Nature. 1990;346:425\u201334.","journal-title":"Nature"},{"key":"922_CR12","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1159\/000094966","volume":"104","author":"XM Qi","year":"2006","unstructured":"Qi XM, Wu GZ, Wu YG, Lin H, Shen JJ, Lin SY. Renoprotective effect of breviscapine through suppression of renal macrophage recruitment in streptozotocin-induced diabetic rats. Nephron Exp Nephrol. 2006;104:e147\u201357.","journal-title":"Nephron Exp Nephrol"},{"key":"922_CR13","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1681\/ASN.2004070612","volume":"16","author":"FY Chow","year":"2005","unstructured":"Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Tesch GH. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db\/db mice. J Am Soc Nephrol. 2005;16:1711\u201322.","journal-title":"J Am Soc Nephrol"},{"key":"922_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s002510000258","volume":"52","author":"OP Kristiansen","year":"2000","unstructured":"Kristiansen OP, Nolsoe RL, Holst H, Reker S, Larsen ZM, Johannesen J, et al. The intercellular adhesion molecule-1 K469E polymorphism in type 1 diabetes. Immunogenetics. 2000;52:107\u201311.","journal-title":"Immunogenetics"},{"key":"922_CR15","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1034\/j.1399-0039.2000.550608.x","volume":"55","author":"S Nejentsev","year":"2000","unstructured":"Nejentsev S, Laine AP, Simell O, Ilonen J. Intercellular adhesion molecule-1 (ICAM-1) K469E polymorphism: no association with type 1 diabetes among Finns. Tissue Antigens. 2000;55:568\u201370.","journal-title":"Tissue Antigens"},{"key":"922_CR16","first-page":"327","volume":"42","author":"C Guja","year":"1999","unstructured":"Guja C, Todd J, Welsh K, Marshall S, Ionescu-Tirgoviste C. Increased transmission of intercellular adhesion-molecule-1, 469E allele in type 1 Romanian diabetic families. Diabetologia. 1999;42:327.","journal-title":"Diabetologia"},{"key":"922_CR17","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/j.1464-5491.2006.01948.x","volume":"23","author":"J Ma","year":"2006","unstructured":"Ma J, Mollsten A, Prazny M, Falhammar H, Brismar K, Dahlquist G, et al. Genetic influences of the intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in development of type 1 diabetes and diabetic nephropathy. Diabet Med. 2006;23:1093\u20139.","journal-title":"Diabet Med"},{"key":"922_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1471-2350-9-47","volume":"9","author":"J Ma","year":"2008","unstructured":"Ma J, Zhang D, Brismar K, Efendic S, Gu HF. Evaluation of the association between the common E469K polymorphism in the ICAM-1 gene and diabetic nephropathy among type 1 diabetic patients in GoKinD population. Bmc Medical Genetics. 2008;9:47.","journal-title":"Bmc Medical Genetics"},{"key":"922_CR19","unstructured":"Chen JN, Xiao-Li LI, Wei JZ. The correlation of the ICAM-1 gene and type II diabetic nephropathy in Zhuang populations in the northern regions of Guilin. Acta Medicinae Sinica. 2010."},{"key":"922_CR20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1440-1797.2006.00566.x","volume":"22","author":"YN Wang","year":"2006","unstructured":"Wang YN, Liu HL, Sun Y. Association of intercellular adhesion molecule-1 gene K469E polymorphism to type 2 diabetic nephropathy. Chinese Journal of Nephrology. 2006;22:201\u20134.","journal-title":"Chinese Journal of Nephrology"},{"key":"922_CR21","doi-asserted-by":"publisher","first-page":"642","DOI":"10.5858\/arpa.2014-0200-OA","volume":"139","author":"JS Ross","year":"2015","unstructured":"Ross JS, Badve S, Wang K, Sheehan CE, Boguniewicz AB, Otto GA, et al. Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options. Arch Pathol Lab Med. 2015;139:642\u20139.","journal-title":"Arch Pathol Lab Med"},{"key":"922_CR22","volume":"6","author":"S Boccia","year":"2009","unstructured":"Boccia S. PRISMA: an attempt to improve standards for reporting systematic review and meta-analysis. Epidemiology Biostatistics & Public Health. 2009;6:E382.","journal-title":"Epidemiology Biostatistics & Public Health"},{"key":"922_CR23","unstructured":"Wells GA, Shea BJ, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle\u2013Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis. Applied Engineering in Agriculture. 2014;18:p\u00e1gs. 727\u2013734."},{"key":"922_CR24","volume-title":"Investigation of the role of ICAM-1 E469K and E-selectin S128R polymorphisms in diabetic neuropathy","author":"E Oguz","year":"2015","unstructured":"Oguz E, Tabur S, Akbas H, Korkmaz H, Torun A, Dilmec F, et al. Investigation of the role of ICAM-1 E469K and E-selectin S128R polymorphisms in diabetic neuropathy. 2015."},{"key":"922_CR25","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jdiacomp.2015.07.004","volume":"29","author":"N Abu Seman","year":"2015","unstructured":"Abu Seman N, Anderstam B, Wan Mohamud WN, Ostenson CG, Brismar K, Gu HF. Genetic, epigenetic and protein analyses of intercellular adhesion molecule 1 in Malaysian subjects with type 2 diabetes and diabetic nephropathy. J Diabetes Complicat. 2015;29:1234\u20139.","journal-title":"J Diabetes Complicat"},{"key":"922_CR26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S2095-4964(16)60255-8","volume":"14","author":"YC Wong","year":"2016","unstructured":"Wong YC. Need of integrated dietary therapy for persons with diabetes mellitus and \"unhealthy\" body constitution presentations. J Integr Med. 2016;14:255\u201368.","journal-title":"J Integr Med"},{"key":"922_CR27","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S2095-4964(16)60267-4","volume":"14","author":"R Chakraborty","year":"2016","unstructured":"Chakraborty R, Roy S, Mandal V. Assessment of traditional knowledge of the antidiabetic plants of Darjeeling and Sikkim Himalayas in the context of recent phytochemical and pharmacological advances. J Integr Med. 2016;14:336\u201358.","journal-title":"J Integr Med."},{"key":"922_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/dmr.5610080402","volume":"8","author":"RF Hamman","year":"1992","unstructured":"Hamman RF. Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Metab Rev. 1992;8:287\u2013338.","journal-title":"Diabetes Metab Rev"},{"key":"922_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1079\/PNS19980029","volume":"57","author":"RE Pratley","year":"1998","unstructured":"Pratley RE. Gene-environment interactions in the pathogenesis of type 2 diabetes mellitus: lessons learned from the Pima Indians. Proc Nutr Soc. 1998;57:175\u201381.","journal-title":"Proc Nutr Soc"},{"key":"922_CR30","doi-asserted-by":"publisher","first-page":"27B","DOI":"10.1016\/j.amjcard.2006.11.004","volume":"99","author":"P Libby","year":"2007","unstructured":"Libby P, Plutzky J. Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists. Am J Cardiol. 2007;99:27B\u201340B.","journal-title":"Am J Cardiol"},{"key":"922_CR31","first-page":"792393","volume":"2010","author":"IA Oever van den","year":"2010","unstructured":"van den Oever IA, Raterman HG, Nurmohamed MT, Simsek S. Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus. Mediat Inflamm. 2010;2010:792393.","journal-title":"Mediat Inflamm"},{"key":"922_CR32","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1161\/01.CIR.0000034509.14906.AE","volume":"106","author":"K Esposito","year":"2002","unstructured":"Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106:2067\u201372.","journal-title":"Circulation"},{"key":"922_CR33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.diabet.2007.10.001","volume":"33","author":"NT Foss","year":"2007","unstructured":"Foss NT, Foss-Freitas MC, Ferreira MA, Cardili RN, Barbosa CM, Foss MC. Impaired cytokine production by peripheral blood mononuclear cells in type 1 diabetic patients. Diabetes Metab. 2007;33:439\u201343.","journal-title":"Diabetes Metab"},{"key":"922_CR34","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jdiacomp.2010.09.003","volume":"25","author":"JF Navarro-Gonzalez","year":"2011","unstructured":"Navarro-Gonzalez JF, Muros M, Mora-Fernandez C, Herrera H, Meneses B, Garcia J. Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results. J Diabetes Complicat. 2011;25:314\u20139.","journal-title":"J Diabetes Complicat"},{"key":"922_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.4239\/wjd.v5.i3.393","volume":"5","author":"MB Duran-Salgado","year":"2014","unstructured":"Duran-Salgado MB, Rubio-Guerra AF. Diabetic nephropathy and inflammation. World J Diabetes. 2014;5:393\u20138.","journal-title":"World J Diabetes"},{"key":"922_CR36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/0971-6866.116126","volume":"19","author":"A Motavallian","year":"2013","unstructured":"Motavallian A, Andalib S, Vaseghi G, Mirmohammad-Sadeghi H, Amini M. Association between PRO12ALA polymorphism of the PPAR-gamma2 gene and type 2 diabetes mellitus in Iranian patients. Indian J Hum Genet. 2013;19:239\u201344.","journal-title":"Indian J Hum Genet"},{"key":"922_CR37","doi-asserted-by":"publisher","first-page":"c213","DOI":"10.1159\/000224787","volume":"112","author":"BR Conway","year":"2009","unstructured":"Conway BR, Maxwell AP. Genetics of diabetic nephropathy: are there clues to the understanding of common kidney diseases? Nephron Clin Pract. 2009;112:c213\u201321.","journal-title":"Nephron Clin Pract"},{"key":"922_CR38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cyto.2008.06.015","volume":"44","author":"Y Wu","year":"2008","unstructured":"Wu Y, Dong J, Yuan L, Liang C, Ren K, Zhang W, et al. Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy. Cytokine. 2008;44:85\u201391.","journal-title":"Cytokine"},{"key":"922_CR39","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1097\/TP.0b013e3181a192bd","volume":"87","author":"S Wittmann","year":"2009","unstructured":"Wittmann S, Daniel C, Stief A, Vogelbacher R, Amann K, Hugo C. Long-term treatment of sirolimus but not cyclosporine ameliorates diabetic nephropathy in the rat. Transplantation. 2009;87:1290\u20139.","journal-title":"Transplantation"},{"key":"922_CR40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1684\/ecn.2012.0309","volume":"23","author":"NM Elsherbiny","year":"2012","unstructured":"Elsherbiny NM, Abd El Galil KH, Gabr MM, Al-Gayyar MM, Eissa LA, El-Shishtawy MM. Reno-protective effect of NECA in diabetic nephropathy: implication of IL-18 and ICAM-1. Eur Cytokine Netw. 2012;23:78\u201386.","journal-title":"Eur Cytokine Netw"},{"key":"922_CR41","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0198-8859(00)00101-4","volume":"61","author":"M Nishimura","year":"2000","unstructured":"Nishimura M, Obayashi H, Maruya E, Ohta M, Tegoshi H, Fukui M, et al. Association between type 1 diabetes age-at-onset and intercellular adhesion molecule-1 (ICAM-1) gene polymorphism. Hum Immunol. 2000;61:507\u201310.","journal-title":"Hum Immunol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0922-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-018-0922-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0922-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T03:54:59Z","timestamp":1605844499000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-018-0922-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["922"],"URL":"https:\/\/doi.org\/10.1186\/s12944-018-0922-2","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"14 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"293"}}